Pipeline · Bill → Law
Step 1
Introduced
Jul 18, 2023
Step 2
Referred
Jul 21, 2023
E&C
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary
This bill requires the Department of Health and Human Services to issue regulations to prevent the misuse of de novo gene synthesis products (i.e., manufactured gene products), including screening protocols for providers of these products. Federal agencies and entities that receive federal funds may only purchase such products from providers that comply with the screening protocols.
Timeline · 3 actions
Jul 21, 2023
Referred to the Subcommittee on Health.
Jul 18, 2023
Introduced in House
Jul 18, 2023
Referred to the House Committee on Energy and Commerce.